Evaluates the impact of carrageenan on inflammation markers in adults, implying caution in supplement use.
This study investigated the association between carrageenan (CGN) in protein supplement beverages and C-reactive protein (CRP), a marker of systemic inflammation, in a nationally-representative survey of US adults. The analysis included 922 adults who reported use of protein supplement beverages and had CRP measurements in the National Health and Nutrition Examination Survey (1999-2010, 2015-2023). In the primary analysis, users of liquid protein beverages (proxy for CGN exposure) were compared with users of beverages prepared with powders (proxy for unexposed). A secondary analysis compared participants using protein beverages with and without CGN (n = 622). Multivariable linear regression evaluated associations between CGN and log-transformed CRP. Overall, use of CGN-containing protein supplements was not significantly associated with CRP (primary ratio:1.07, 95%CI:0.74-1.55; secondary:0.98, 95%CI:0.66-1.47). However, some differences by health status (p-interaction = 0.04) were observed, with some suggestions of association among participants reporting poorer health (primary:1.91, 95%CI:0.92-3.97; secondary:3.14, 95%CI:1.43-6.91). No significant interactions were found for age, gender, obesity, or time, despite some suggestive evidence of associations in younger adults and females. Use of CGN-containing protein supplement beverages was not associated with higher CRP overall, but hypothesis-generating data warrant future larger studies to evaluate the role of CGN on inflammation in specific population subgroups.
No takes yet. Share an insight, caveat, or question.
Lam et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: